Metraipolis › archive › dc_0256865e324f
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit — Europe PMC PMID:40862547
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40862547
- DOI
- 10.1158/2767-9764.crc-25-0033
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:59:52.685Z
- SHA-256 of the archived text
666cb68c0798e5d411f8468e83f6e042c98232a58d75b99ace05448480010d66- Stable URL of this page
https://metraipolis.com/documento/dc_0256865e324f
How to cite
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit — Europe PMC PMID:40862547 — Europe PMC (en), https://europepmc.org/article/MED/40862547 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0256865e324f (Metraipolis archive dc_0256865e324f, sha256 666cb68c0798e5d411f8468e83f6e042c98232a58d75b99ace05448480010d66)
BibTeX
@misc{dc0256865e324f,
title = {Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit — Europe PMC PMID:40862547},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40862547},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0256865e324f; sha256 666cb68c0798e5d411f8468e83f6e042c98232a58d75b99ace05448480010d66},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40862547. Agents can read the archived copy with the MCP tool read_document.